Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs

Go back to Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs
(NASDAQ: IMTX) Delayed: 8.75 -0.36 (3.95%)
Previous Close $9.11    52 Week High
Open $9.02    52 Week Low
Day High $9.09    P/E N/A 
Day Low $8.66    EPS
Volume 798,776